Business Description
American Oncology Network Inc
NAICS : 621498
SIC : 8051
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 5.88 | |||||
Debt-to-EBITDA | -2.82 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 2.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 36 | |||||
3-Year EPS without NRI Growth Rate | 13 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 11.92 | |||||
Days Sales Outstanding | 33.02 | |||||
Days Payable | 41.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -10.86 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 4.99 | |||||
Operating Margin % | -3.1 | |||||
Net Margin % | -0.67 | |||||
ROA % | -2.41 | |||||
ROIC % | -27.73 | |||||
ROC (Joel Greenblatt) % | -72.63 | |||||
ROCE % | -33.94 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
PS Ratio | 0.02 | |||||
Price-to-Free-Cash-Flow | 1.79 | |||||
Price-to-Operating-Cash-Flow | 0.85 | |||||
EV-to-FCF | -10.97 | |||||
FCF Yield % | -22.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AONCW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
American Oncology Network Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0 - 0.4995 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
American Oncology Network Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
American Oncology Network Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
American Oncology Network Inc Frequently Asked Questions
What is American Oncology Network Inc(AONCW)'s stock price today?
When is next earnings date of American Oncology Network Inc(AONCW)?
Does American Oncology Network Inc(AONCW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |